Phetharbital

Phetharbital (phenetharbital) is a barbiturate derivative. It has anticonvulsant effects and relatively weak sedative action, and is considered to have a low abuse potential.[1]

Phetharbital
Clinical data
Other namesPhetharbital
ATC code
  • none
Identifiers
  • 1-Phenyl-5,5-diethyl-1,3-diazinane-2,4,6-trione
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.006.015
Chemical and physical data
FormulaC14H16N2O3
Molar mass260.293 g·mol−1
3D model (JSmol)
  • c2ccccc2N(C1=O)C(=O)NC(=O)C1(CC)CC
  • InChI=1S/C14H16N2O3/c1-3-14(4-2)11(17)15-13(19)16(12(14)18)10-8-6-5-7-9-10/h5-9H,3-4H2,1-2H3,(H,15,17,19) ☒N
  • Key:ILORKHQGIMGDFN-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

References
  1. Eddy NB, Halbach H, Isbell H, Seevers MH (1965). "Drug dependence: Its significance and characteristics". Bulletin of the World Health Organization. 32 (5): 721–733. PMC 2555251. PMID 5294186.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.